Pancreatic Cancer Research

ResearcherLyon 1 UniversitéActive in the last 2 years

Élodie Roger

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4930-6292; OpenAlex author ID A5011655250. Sources: OpenAlex.

Their work

Papers
14 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
54
Papers, trials and grants by year

2019: 1 paper · 2020: 2 papers · 2021: 4 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 3 papers · 2026: 3 papers

Papers 14

  1. DKK3 Initially Preserves Acinar Integrity Through MEK-Fos Signaling, but Later Switches to an Oncogenic Role in Pancreatic Cancer. First author DOI 10.1002/advs.202417606↗
  2. ATM Deficiency Induces TGFβ-Mediated Stromal Programming in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-26-0138↗
  3. An oncogenic KRAS-driven secretome involving TNFα promotes niche preparation prior to pancreatic cancer onset. Co-author DOI 10.1186/s12943-025-02541-1↗
  4. Homologous Repair-Deficient Pancreatic Cancer: Refined Targeting of DNA Damage Response is an Effective Therapeutic Strategy. Co-author DOI 10.1002/ueg2.12773↗
  5. Tumor microenvironment subtyping in pancreatic ductal adenocarcinoma: New avenues for personalized therapeutic strategies. Last author DOI 10.1016/j.addr.2025.115697↗
  6. Pancreatic cancer patient-derived organoids capture therapy response and tumor evolution Co-author DOI 10.1101/2025.04.24.650216↗
  7. State-matched organoid models to fight pancreatic cancer. First author DOI 10.1016/j.trecan.2022.03.003↗
  8. Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer. Co-author DOI 10.1136/gutjnl-2019-319970↗
  9. DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives. Co-author DOI 10.1136/gutjnl-2019-319984↗
  10. RINT1 Regulates SUMOylation and the DNA Damage Response to Preserve Cellular Homeostasis in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-20-2633↗
  11. A Prospective Feasibility Trial to Challenge Patient-Derived Pancreatic Cancer Organoids in Predicting Treatment Response. Co-author DOI 10.3390/cancers13112539↗
  12. Correction: Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling. Co-author DOI 10.1038/s41419-020-2262-1↗
  13. Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Based Chemotherapy. Co-author DOI 10.3390/cells9092110↗
  14. Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling. Co-author DOI 10.1038/s41419-019-2116-x↗

Closest collaborators

The 25 strongest of 54 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alexander Kleger · 12 shared papers, 2020–2026 · strength 2.19
  2. Johann Gout · 10 shared papers, 2020–2026 · strength 1.73
  3. Thomas Theodor Werner Seufferlein · 10 shared papers, 2020–2026 · strength 1.56
  4. Lukas Perkhofer · 9 shared papers, 2020–2026 · strength 1.37
  5. Dharini Srinivasan · 5 shared papers, 2025–2026 · strength 1.14
  6. Michael Karl Melzer · 4 shared papers, 2022–2026 · strength 0.86
  7. Frank Arnold · 5 shared papers, 2020–2026 · strength 0.69
  8. Alica K. Beutel · 4 shared papers, 2020–2025 · strength 0.64
  9. Hans Armin Kestler · 4 shared papers, 2021–2025 · strength 0.47
  10. Christopher J. Halbrook · 2 shared papers, 2025–2026 · strength 0.42
  11. Chantal Allgöwer · 2 shared papers, 2026 · strength 0.42
  12. Matthias J. Löhr · 2 shared papers, 2026 · strength 0.40
  13. Thomas Jens Ettrich · 3 shared papers, 2021–2025 · strength 0.39
  14. Martin Müller · 3 shared papers, 2020–2021 · strength 0.30
  15. Marko Kornmann · 2 shared papers, 2021–2025 · strength 0.29
  16. Patrick Christian Hermann · 2 shared papers, 2021–2026 · strength 0.27
  17. Roland Rad · 2 shared papers, 2021–2026 · strength 0.27
  18. Peter Möller · 1 shared paper, 2026 · strength 0.22
  19. Paolo Riccardo Camisa · 1 shared paper, 2026 · strength 0.19
  20. Benedetta Ferrara · 1 shared paper, 2026 · strength 0.19
  21. Claus Jørgensen · 1 shared paper, 2026 · strength 0.19
  22. Anton Lahusen · 1 shared paper, 2026 · strength 0.19
  23. Lorenzo Piemonti · 1 shared paper, 2026 · strength 0.19
  24. Stefano Crippa · 1 shared paper, 2026 · strength 0.19
  25. Karolin Walter · 2 shared papers, 2021 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.